Pfizer Inc
NYSE: PFE
$29.38
+$0.07 (+0.2%)
Real Time Data Delayed 15 Min.
PFE Articles
All indexes rebalance on a quarterly basis. 24/7 Wall St. screened a recent Jefferies report for the stocks that will see the most trading on Friday's rebalance.
Published:
While the selling that was reported this week was consistent with what we have seen so far in March, nothing indicates a mass exodus for shareholders at this point.
Published:
Among most shorted stocks trading on the New York Stock Exchange, Petrobras and Pfizer saw the largest declines in the percentage of shares short in late February.
Published:
With AT&T dropped from the Dow in favor of Apple, investors may be wondering which Dow stocks could get booted from the index next.
Published:
Here are five new members of the Credit Suisse Top Picks list in five separate market sectors. They look poised for a solid remainder of 2015.
Published:
Frank Golhen, via Wikimedia CommonsSurges in short interest between the January 30 and February 13 settlement dates lifted Pfizer and Verizon Communications into the top five most shorted stocks on...
Published:
We combined two Merrill Lunch ideas that secular contrarians should be long, or own now, and screened the firm's stocks universe for large-cap dividend yield stocks that are rated Buy.
Published:
One area that makes sense for growth investors is the large cap pharmaceuticals. Here are some the top pharmaceutical stocks to buy now according to Jefferies.
Published:
thinkstockFebruary 10, 2015: Markets opened higher on Tuesday as every sector except energy and basic materials posted solid gains on the day. Crude oil settled at near $50.00, down more than 5% for...
Published:
Last Updated:
Monday's top analyst upgrades, downgrades and initiations include AbbVie, Alcoa, Apple, Deckers Outdoor, Dish Network, Pfizer and Petrobras.
Published:
thinkstockFebruary 5, 2015: Markets opened higher on Thursday on news that the Bank of Greece would continue to be able to access funds from the European Central Bank, at least for a while. New...
Published:
Last Updated:
If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today.
Published:
Amidst the excitement about Facebook's nearly 50% revenue growth rate and its successful, accelerating movement into mobile, something is lost.
Published:
Pfizer reported better-than-expected fourth-quarter earnings Tuesday before the U.S. markets opened.
Published:
Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year to date, Its shares are up 11%.
Published:
Last Updated: